Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof

Patent 11993651 was granted and assigned to Agenus on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Agenus
Agenus
0
Date Filed
November 20, 2020
0
Date of Patent
May 28, 2024
0
Patent Applicant
Agenus
Agenus
0
Patent Application Number
17100038
0
Patent Citations
‌
US Patent 7411057 Nucleic acids encoding human monoclonal antibodies to CTLA-4
0
‌
US Patent 7488802 Antibodies against PD-1
0
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs
0
‌
US Patent 7858589 Compositions of CpG and saponin adjuvants and uses thereof
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 7951917 Method for making multispecific antibodies having heteromultimeric and common components
0
‌
US Patent 7972993 Identification of protein binding sites
0
‌
US Patent 8088449 Reinforced silicone resin film and method of preparing same
0
‌
US Patent 8114845 Compositions of PD-1 antagonists and methods of use
0
•••
Patent Inventor Names
David Adam Savitsky
0
Cornelia Anne Mundt
0
Marc van Dijk
0
Nicholas Stuart Wilson
0
Shawn Michael Jennings
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11993651
0
Patent Primary Examiner
‌
Michail A Belyavskyi
0

Find more entities like US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo